Transcript of the December 4, 2025 earnings call highlights HCG's oncology focus, EBITDA margin uplift at mature centers, and a target ROCE of 20%+ over the next five years.
AI Assistant
Healthcare Global Enterprises Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.